Imatinib vs Upadacitinib
Imatinib vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Imatinib and Upadacitinib.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Imatinib β 18 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O; Upadacitinib β C17H19F3N6O.
Molecular Weight: Imatinib β 493.6030 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Imatinib β Small molecule; Upadacitinib β Small molecule.